Avoiding lodging in irrigated spring wheat. II. Genetic variation of stem and root structural properties

Lodging-related traits were evaluated on the CIMMYT Core spring wheat Germplasm Panel (CIMCOG) in the Yaqui Valley of North-West Mexico during three seasons (2010–2013). Genetic variation was significant for all the lodging-related traits in the cross-year analysis, however, significant G × E interaction due to rank changes or changes in the absolute differences between cultivars were identified. The inconsistences on cultivar performances across seasons particularly reduced the heritability of key characters related to root lodging resistance (anchorage strength). Target characters related to stem lodging resistance (stem strength) showed good heritability values equal or above 0.70. Positive correlations between stem strength and stem diameter and between root plate spread and root strength were found. Selecting for greater stem diameter and wall width, greater root plate spread and shorter plant height could enable breeders to increase lodging resistance by increasing stem strength, root strength and decreasing plant leverage, respectively. Achieving a lodging-proof crop will depend on finding a wider root plate spread and implementing new management strategies. Genetic linkages between lodging traits will not constrain the combination of the key lodging-trait dimensions to achieve a lodging-proof ideotype. However, strong association between stem strength and stem wall width will increase the total biomass cost needed for lodging resistance

Avoiding lodging in irrigated spring wheat. I. Stem and root structural requirements

A model of the lodging process has been successfully adapted for use on spring wheat grown in North-West Mexico (NWM). The lodging model was used to estimate the lodging-associated traits required to enable spring wheat grown in NWM with a typical yield of 6 t ha−1 and plant height of 0.7 m to achieve a lodging return period of 25 years. Target traits included a root plate spread of 51 mm and stem strength of the bottom internode of 268 N mm. These target traits increased to 54.5 mm and 325 N mm, respectively, for a crop yielding 10 t ha−1. Analysis of multiple genotypes across three growing seasons enabled relationships between both stem strength and root plate spread with structural dry matter to be quantified. A NWM lodging resistant ideotype yielding 6 t ha−1 would require 3.93 t ha−1 of structural stem biomass and 1.10 t ha−1 of root biomass in the top 10 cm of soil, which would result in a harvest index (HI) of 0.46 after accounting for chaff and leaf biomass. A crop yielding 10 t ha−1 would achieve a HI of 0.54 for 0.7 m tall plants or 0.41 for more typical 1.0 m tall plants. This study indicates that for plant breeders to achieve both high yields and lodging-proofness they must either breed for greater total biomass or develop high yielding germplasm from shorter crops

Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study

BACKGROUND & OBJECTIVES: Vaccine safety signals require investigation, which may be done rapidly at the population level using ecological studies, before embarking on hypothesis-testing studies. Incidence rates were used to assess a signal of narcolepsy following AS03-adjuvanted monovalent pandemic H1N1 (pH1N1) influenza vaccination among children and adolescents in Sweden and Finland in 2010. We explored the utility of ecological data to assess incidence of narcolepsy following exposure to pandemic H1N1 virus or vaccination in 10 sites that used different vaccines, adjuvants, and had varying vaccine coverage.METHODS: We calculated incidence rates of diagnosed narcolepsy for periods defined by influenza virus circulation and vaccination campaign dates, and used Poisson regression to estimate incidence rate ratios (IRRs) comparing the periods during which wild-type virus circulated and after the start of vaccination campaigns vs. the period prior to pH1N1 virus circulation. We used electronic health care data from Sweden, Denmark, the United Kingdom, Canada (3 provinces), Taiwan, Netherlands, and Spain (2 regions) from 2003 to 2013. We investigated interactions between age group and adjuvant in European sites and conducted a simulation study to investigate how vaccine coverage, age, and the interval from onset to diagnosis may impact the ability to detect safety signals.RESULTS: Incidence rates of narcolepsy varied by age, continent, and period. Only in Taiwan and Sweden were significant time-period-by-age-group interactions observed. Associations were found for children in Taiwan (following pH1N1 virus circulation) and Sweden (following vaccination). Simulations showed that the individual-level relative risk of narcolepsy was underestimated using ecological methods comparing post- vs. pre-vaccination periods; this effect was attenuated with higher vaccine coverage and a shorter interval from disease onset to diagnosis.CONCLUSIONS: Ecological methods can be useful for vaccine safety assessment but the results are influenced by diagnostic delay and vaccine coverage. Because ecological methods assess risk at the population level, these methods should be treated as signal-generating methods and drawing conclusions regarding individual-level risk should be avoided

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment

Background: In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To further assess a possible association and inform policy on future use of adjuvants, we conducted a multi-country study of narcolepsy and adjuvanted pH1N1 vaccines. Methods: We used electronic health databases to conduct a dynamic retrospective cohort study to assess narcolepsy incidence rates (IR) before and during pH1N1 virus circulation, and after pH1N1 vaccination campaigns in Canada, Denmark, Spain, Sweden, Taiwan, the Netherlands, and the United Kingdom. Using a case-control study design, we evaluated the risk of narcolepsy following AS03- and MF59-adjuvanted pH1N1 vaccines in Argentina, Canada, Spain, Switzerland, Taiwan, and the Netherlands. In the Netherlands, we also conducted a case-coverage study in children born between 2004 and 2009. Results: No changes in narcolepsy IRs were observed in any periods in single study sites except Sweden and Taiwan; in Taiwan incidence increased after wild-type pH1N1 virus circulation and in Sweden (a previously identified signaling country), incidence increased after the start of pH1N1 vaccination. No association was observed for Arepanrix-AS03 or Focetria-MF59 adjuvanted pH1N1 vaccines and narcolepsy in children or adults in the case-control study nor for children born between 2004 and 2009 in the Netherlands case-coverage study for Pandemrix-AS03. Conclusions: Other than elevated narcolepsy IRs in the period after vaccination campaigns in Sweden, we did not find an association between AS03- or MF59-adjuvanted pH1N1 vaccines and narcolepsy in children or adults in the sites studied, although power to evaluate the AS03-adjuvanted Pandemrix brand vaccine was limited in our study